
Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Dr. Gordon Smith talks with Dr. Vera Bril about exploring the potential use of immunoglobulin as a corticosteroid-sparing agent in patients with Myasthenia Gravis.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.